I agree completely!
In the most simplistic terms, the following sequence of events happens:
1) The insurance companies pay an amount (R = revenue) for the services that pathologists provide
2) Companies look for opportunities to make/maximize a profit.
Profits of companies = revenue - Costs
3) Pathologists are in oversupply. Companies can pay pathologists a lower income because pathologists have no other employment opportunities.
Labor costs from the companies' perspective go down.
4) Profits of companies = Revenue - (LOW COSTS) = HIGH PROFIT OPPORTUNITY
5) Companies open up labs as they see this as a great opportunity to make $$$$
Imagine a different (ideal) scenario.
If pathologists were in demand, then labor costs would go up. Then, Profits of companies = Revenue - (HIGH COSTS) = LOW PROFIT OPPORTUNITY.
The companies would then have little incentive to cash in, open up hundreds of labs in the country, and exploit pathologists.
I know some people will dismiss all of this and say that all specialties in medicine have a worse outlook than in the past. But I beg to differ that the problem we pathologists face is unique. What other field has corporations eating away at the reimbursements insurance companies give us? We get screwed over by both insurance companies and corporations, a double whammy. And it's too bad people can't understand the simple economics of supply and demand. While pathology organizations are sitting around doing nothing to address to problem and releasing hardly reassuring surveys of the job market, corporations are probably lobbying to increase the number of pathology residency spots to profit even more off us.
If a survey says that 94% of pathologists are decrying too few jobs, then representatives of pathology organizations should do something. After all, shouldn't pathology organizations heed to the concerns of their constituents and be democratic?
Having too few primary care physicians/gynecologists//general surgeons/physicians who does biopsies but too many pathologists is bad public policy. It's like running a grocery store with 1 person stocking the shelves, 4 cashiers, 10 store managers, 30 marketing executives and 40 executive board members. The person stocking the shelves is working his butt off while the successive people are sitting around doing nothing, because the limiting factor for their workload is the person before them.
The whole corporate "mess" is simply exploitation due to oversupply. If there were fewer pathologists these corporate entities would actually have to pay them "fairly" for the work they do. This would kill the money incentive and hence the corporate intrusion. Samething with the pod labs. With all these problems due to oversupply, it "baffles" me why the pathology organizations are silent on the oversupply issue. Is there some sort of collusion going on? or do we just suffer from uncaring and self absorbed leadership with very poor business sense who likes to talk about transformation but does not address real issues that would actually benefit all?
Why is the oversupply problem not being highlighted (even the survey had 94% participants decrying too few jobs?). What sort of evidence are we waiting for? What is actually going on?
It is very clear to me: the only real problem confronting pathology is oversupply. Addressing this problem in a direct manner would be the panacea for all our problems. There is a critical and urgent need to decrease the number of graduating pathologists, to treat this "plague", otherwise the havoc will continue and we will sink deeper and deeper till our very viability is questionable.
Now is the time to correct the mistake of our "thoughtless" forbears, so that the present and future generation of pathologists do not suffer this bullsh-t and we assume our "well deserved" role at the top of the food chain in medicine (unlike the present where we are just slaves to make money for the next slavemaster, be it a corporate entity, in-office lab or some academic institution).
Now is the right time, everyone is receptive to increasing positions in primary care. All we need is to voice the oversupply problem. The money funding excess pathology residencies can go to primary care residencies. Win-win.